Connection
Ronald Sokol to Infliximab
This is a "connection" page, showing publications Ronald Sokol has written about Infliximab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.179 |
|
|
|
-
El Kasmi KC, Anderson AL, Devereaux MW, Balasubramaniyan N, Suchy FJ, Orlicky DJ, Shearn CT, Sokol RJ. Interrupting tumor necrosis factor-alpha signaling prevents parenteral nutrition-associated cholestasis in mice. JPEN J Parenter Enteral Nutr. 2022 07; 46(5):1096-1106.
Score: 0.179